April 08, 2014; 82 (10 Supplement) April 29, 2014
GNbAC1, a Humanized Monoclonal Antibody Against The Multiple Sclerosis Associated Retrovirus Envelope Protein, Is Well Tolerated In Patients With Multiple Sclerosis. (P2.217)
Tobias Derfuss, Francois Curtin, Alois Lang, Herve Perron, Ludwig Kappos, Patrice LaLive
First published April 9, 2014,
Tobias Derfuss
4Neurologische Uniklinik Basel Basel Switzerland
Francois Curtin
2GeNeuro SA Geneva Switzerland
Alois Lang
3GeNeuro SA Plan les Ouates Switzerland
Herve Perron
3GeNeuro SA Plan les Ouates Switzerland
Ludwig Kappos
5Neurology and Department of Biomedicine, University Hospital Basel Switzerland
Patrice LaLive
1Geneva Switzerland
GNbAC1, a Humanized Monoclonal Antibody Against The Multiple Sclerosis Associated Retrovirus Envelope Protein, Is Well Tolerated In Patients With Multiple Sclerosis. (P2.217)
Tobias Derfuss, Francois Curtin, Alois Lang, Herve Perron, Ludwig Kappos, Patrice LaLive
Neurology Apr 2014, 82 (10 Supplement) P2.217;
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 82 no. 10 Supplement P2.217
Print ISSN:
Online ISSN:
History:
- First Published April 9, 2014.
Copyright & Usage:
Copyright © 2014 by AAN Enterprises, Inc.
Author Disclosures
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.